Golfer247 - The latest news and products from the world of golf
Main Menu | News By Date | News By Supplier | News By Category | About Us
 

BTG LICENSES FUNDAMENTAL ONLINE NAVIGATION TRACKING PATENTS TO NETFLIX
25 September 2006 - BTG

BTG plc announced it has reached a full and final settlement with Netflix Inc. in connection with a patent infringement lawsuit filed by BTG in September 2004 against Netflix and other organisations. As a result of this settlement, BTG has dismissed its claims against Netflix and granted Netflix a non-exclusive licence to patents covering technology for tracking the navigational path of a user through the World Wide Web.

BTG plc announced it has reached a full and final settlement with Netflix Inc. in connection with a patent infringement lawsuit filed by BTG in September 2004 against Netflix and other organisations. As a result of this settlement, BTG has dismissed its claims against Netflix and granted Netflix a non-exclusive licence to patents covering technology for tracking the navigational path of a user through the World Wide Web. The suit against the other parties, Amazon.com, BarnesandNoble.com and Overstock.com, continues to be pursued. The financial terms of the settlement with Netflix are undisclosed.

Louise Makin, Chief Executive Officer of BTG, commented: “We are pleased to have reached an agreement with Netflix, validating our confidence in these patents, which we believe to be fundamental to effective online advertising and affiliate programs. We will continue to move forward vigorously with the patent infringement suit against the other parties, and we anticipate that the total revenue potential of this technology is of material significance to BTG.”

In September 2004, BTG filed suit in Federal Court in Delaware against Amazon.com, BarnesandNoble.com, Netflix and Overstock.com for infringement of patented technology that enables efficient tracking of the movement of Internet users between websites and is used in certain online marketing programs.

http://www.btgplc.com

About: BTG
BTG is an intellectual property and technology commercialisation company that operates internationally. BTG creates value by investing in intellectual property and technology development, and in early stage ventures. We realise value through technology licensing, patent assertion and sale of equity investments. Through a multidisciplinary approach, we apply intellectual property and commercial expertise, together with specialist skills in science and technology, to create major product opportunities in the health and high tech sectors. BTG has commercialised important innovations, including Magnetic Resonance Imaging, Multilevel Cell Memory, Campath (alemtuzumab), the first monoclonal antibody treatment for chronic lymphocytic leukaemia, and recombinant Factor IX blood clotting protein. BTG operates through wholly owned subsidiaries BTG International Ltd and BTG International Inc in the UK and USA, respectively.


More News:
  • For September 2006
  • From BTG
  • For Polymer OLED Devices

 
©2008 New Materials International